Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine - 1 Dec 2007

Daniels G, Finning K, Martin P, Summers J

Abstract excerpt

The most important application of blood group genotyping by molecular genetics is the prediction of fetal RhD phenotype in pregnant women with anti-D, in order to assess the risk of haemolytic disease of the fetus and newborn. This diagnostic test performed on cell-free fetal DNA in the maternal plasma, is now a routine procedure in some countries. High-throughput modifications of this form of fetal D-typing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal Blood
Share to Fetal Diseases
Share to Isoantibodies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pregnancy

Share to Prenatal Diagnosis

Share to Rh-Hr Blood-Group System

Share to Rh Isoimmunization

Share to Rho(D) Immune Globulin

Source

Identifiers

PMID: 18436463
DOI: 10.1016/j.tracli.2008.03.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.PMID 18436463Read ↗

Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.Semantic proximity Read ↗

Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects.Semantic proximity Read ↗

Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.Semantic proximity Read ↗

Noninvasive fetal blood grouping: present and future.Semantic proximity Read ↗

RHD genotyping from maternal plasma: guidelines and technical challenges.Semantic proximity Read ↗

[Value of RHD fetal genotyping in the prevention of anti-D immunization].Semantic proximity Read ↗

Fetal blood group genotyping: present and future.Semantic proximity Read ↗

A Clinical Service in the UK to Predict Fetal Rh (Rhesus) D Blood Group Using Free Fetal DNA in Maternal PlasmaSemantic proximity Read ↗

Investigation of discrepancies obtained during 15 years of non-invasive fetal RHD genotyping in apparent serologic RhD-negative pregnant women.Semantic proximity Read ↗

Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women.Semantic proximity Read ↗

Noninvasive fetal RhD genotyping from maternal blood.Semantic proximity Read ↗

No. 343-Routine Non-invasive Prenatal Prediction of Fetal RHD Genotype in Canada: The Time is Here.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.